Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy.
Hum Vaccin Immunother. 2021 Jul 3;17(7):2225-2231. doi: 10.1080/21645515.2020.1855951. Epub 2021 Jan 31.
Hum Vaccin Immunother. 2021.
PMID: 33522380
Free PMC article.
The four-component meningococcal serogroup B vaccine (4CMenB) contains antigens present in the majority of meningococci causing invasive meningococcal disease (IMD) and may potentially offer protection against strains belonging to non-B serogroups.This study aimed t …
The four-component meningococcal serogroup B vaccine (4CMenB) contains antigens present in the majority of meningococci causing invas …